Anr and its activation by PlcH activity in Pseudomonas aeruginosa host colonization and virulence

Journal of Bacteriology

Volumn 195, Issue 13, 2013, Pages 3093-3104

  Jackson, Angelyca A ^a   Gross, Maegan J ^a   Daniels, Emily F ^a   Hampton, Thomas H ^a   Hammond, John H ^a   Vallet Gely, Isabelle ^b,c   Dove, Simon L ^b   Stanton, Bruce A ^a   Hogan, Deborah A ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c CENTRE DE GÉNÉTIQUE MOLÉCULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANR PROTEIN; BACTERIAL PROTEIN; BETAINE; CHOLINE; LUNG SURFACTANT; OXYGEN; PHOSPHATIDYLCHOLINE; PHOSPHOLIPASE C; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL METABOLISM; BACTERIAL VIRULENCE; BACTERIUM CULTURE; CELL MEMBRANE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SYNTHESIS; EPITHELIUM CELL; HOST PATHOGEN INTERACTION; LIPID DEGRADATION; MICROARRAY ANALYSIS; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REGULON;

ANIMALS; BACTERIAL PROTEINS; GENE EXPRESSION REGULATION, BACTERIAL; MALE; MICE; MICE, INBRED C57BL; PSEUDOMONAS AERUGINOSA; TRANS-ACTIVATORS; TRANSFERASES (OTHER SUBSTITUTED PHOSPHATE GROUPS); VIRULENCE;

ANIMALIA; BACTERIA (MICROORGANISMS); PSEUDOMONAS AERUGINOSA;

EID: 84880018817     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.02169-12     Document Type: Article

References (70)

1. Van Delden C, Iglewski BH. 1999. Cell-to-cell signaling and Pseudomonas aeruginosa infections. Emerg. Infect. Dis. 4:551-560.
2. Rajan S, Saiman L. 2002. Pulmonary infections in patients with cystic fibrosis. Semin. Respir. Infect. 17:47-56.
3. Smith EE, Buckley DG, Wu Z, Saenphimmachak C, Hoffman LR, D'Argenio DA, Miller SI, Ramsey BW, Speert DP, Moskowitz SM, Burns JL, Kaul R, Olson MV. 2006. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc. Natl. Acad. Sci. U. S. A. 103:8487-8492.
4. Bomberger J, MacEachran DP, Coutermarsh BA, Ye S, O'Toole GA, Stanton B. 2009. Long-distance delivery of bacterial virulence factors by Pseudomonas aeruginosa outer membrane vesicles. PLoS Pathog. 5:e1000382. doi:10.1371/journal.ppat.1000382.
5. Berka RM, Vasil ML. 1982. Phospholipase C (heat-labile hemolysin) of Pseudomonas aeruginosa: purification and preliminary characterization. J. Bacteriol. 152:239-245.
6. Vasil M. 2006. Pseudomonas aeruginosa phospholipases and phospholipids, p 69-97. In Ramos J, Levesque R (ed), Pseudomonas, vol 4. Springer, Houten, The Netherlands.
7. Meyers DJ, Palmer KC, Bale LA, Kernacki K, Preston M, Brown T, Berk RS. 1992. In vivo and in vitro toxicity of phospholipase C from Pseudomonas aeruginosa. Toxicon 30:161-169.
8. Wargo MJ, Ho TC, Gross MJ, Whittaker LA, Hogan DA. 2009. GbdR regulates Pseudomonas aeruginosa plcH and pchP transcription in response to choline catabolites. Infect. Immun. 77:1103-1111.
9. Granstrǒm M, Ericsson A, Strandvik B, Wretlind B, Pavlovskis OR, Berka R, Vasil ML. 1984. Relation between antibody response to Pseudomonas aeruginosa exoproteins and colonization/infection in patients with cystic fibrosis. Acta Paediatr. Scand. 73:772-777.
10. Malek A, Chen C, Wargo MJ, Beattie GA, Hogan DA. 2011. Roles of three transporters, CbcXWV, BetT1, and BetT3, in Pseudomonas aeruginosa choline uptake for catabolism. J. Bacteriol. 193:3033-3041.
11. Serra A, Mariscotti JF, Barra JL, Lucchesi GI, Domenech CE, Lisa AT. 2002. Glycine betaine transmethylase mutant of Pseudomonas aeruginosa. J. Bacteriol. 184:4301-4303.
12. Wargo MJ, Szwergold BS, Hogan DA. 2008. Identification of two gene clusters and a transcriptional regulator required for Pseudomonas aeruginosa glycine betaine catabolism. J. Bacteriol. 190:2690-2699.
13. Høiby N, Krogh Johansen H, Moser C, Song Z, Ciofu O, Kharazmi A. 2001. Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth. Microbes Infect. 3:23-35.
14. Brooun A, Liu S, Lewis K. 2000. A dose-response study of antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 44:640-646.
15. Costerton JW. 2001. Cystic fibrosis pathogenesis and the role of biofilms in persistent infection. Trends Microbiol. 9:50-52.
16. Sawers R. 1991. Identification and molecular characterization of a transcriptional regulator from Pseudomonas aeruginosa PAO1 exhibiting structural and functional similarity to the Fnr protein of Escherichia coli. Mol. Microbiol. 5:1469-1481.
17. Ye RW, Haas D, Ka JO, Krishnapillai V, Zimmermann A, Baird C, Tiedje JM. 1995. Anaerobic activation of the entire denitrification pathway in Pseudomonas aeruginosa requires Anr, an analog of Fnr. J. Bacteriol. 177:3606-3609.
18. Schreiber K, Krieger R, Benkert B, Eschbach M, Arai H, Schobert M, Jahn D. 2007. The anaerobic regulatory network required for Pseudomonas aeruginosa nitrate respiration. J. Bacteriol. 189:4310-4314.
19. Son MS, Matthews WJ, Jr, Kang Y, Nguyen DT, Hoang TT. 2007. In vivo evidence of Pseudomonas aeruginosa nutrient acquisition and pathogenesis in the lungs of cystic fibrosis patients. Infect. Immun. 75:5313-5324.
20. Galimand M, Zimmermann GMA, Haas D. 1991. Positive Fnr-like control of anaerobic arginine degradation and nitrate respiration in Pseudomonas aeruginosa. J. Bacteriol. 173:1598-1606.
21. Lazazzera BA, Beinert H, Khoroshilova N, Kennedy MC, Kiley PJ. 1996. DNA binding and dimerization of the Fe-S-containing FNR protein from Escherichia coli are regulated by oxygen. J. Biol. Chem. 271:2762-2768.
22. Petrova O, Shurr JR, Shurr MJ, Sauer K. 2012. Microcolony formation by the opportunistic pathogen Pseudomonas aeruginosa requires pyruvate and pyruvate fermentation. Mol. Microbiol. 86:819-835.
23. Hassett DJ, Sutton MD, Schurr MJ, Herr AB, Caldwell CC, Matu JO. 2009. Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways. Trends Microbiol. 17:130-138.
24. Marteyn B, West NP, Browning DF, Cole JA, Shaw JG, Palm F, Mounier J, Prevost MC, Sansonetti P, Tang CM. 2010. Modulation of Shigella virulence in response to available oxygen in vivo. Nature 465:355-358.
25. Mattoo S, Ming YH, Huang LL, Miller JF. 2004. Regulation of type III secretion in Bordetella. Mol. Microbiol. 52:1201-1214.
26. Baltes N, N'diaye M, Jacobsen ID, Maas A, Buettner FF, Gerlach GF. 2005. Deletion of the anaerobic regulator HlyX causes reduced colonization and persistence of Actinobacillus pleuropneumoniae in the porcine respiratory tract. Infect. Immun. 73:4614-4619.
27. Bartolini E, Frigimelica E, Giovinazzi S, Galli G, Shaik Y, Genco C, Welsch JA, Granoff DM, Grandi G, Grifantini R. 2006. Role of FNR and FNR-regulated, sugar fermentation genes in Neisseria meningitidis infection. Mol. Microbiol. 60:963-972.
28. Neidhardt FC, Bloch PL, Smith DF. 1974. Culture medium for enterobacteria. J. Bacteriol. 119:736-747.
29. Shortridge VD, Lazdunski A, Vasil ML. 1992. Osmoprotectants and phosphate regulate expression of phospholipase C in Pseudomonas aeruginosa. Mol. Microbiol. 6:863-871.
30. Shanks R, Caiazza NC, Hinsa SM, Toutain CM, O'Toole GA. 2006. Saccharomyces cerevisiae-based molecular tool kit for manipulation of genes from gram-negative bacteria. Appl. Environ. Microbiol. 72:5027-5036.
31. Choi KH, Schweizer HP. 2006. Mini-Tn7 insertion with single attTn7 sites: example Pseudomonas aeruginosa. Nat. Protoc. 1:153-161.
32. O'Toole GA, Kolter R. 1998. Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol. Microbiol. 28:449-461.
33. Cozens AL, Yezzi MJ, Kunzelmann K, Ohrui T, Chin L, Eng K, Finkbeiner WE, Widdicombe JH, Gruenert DC. 1994. CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 10:38-47.
34. Kurioka S, Matsuda M. 1976. Phospholipase C assay using p-nitrophenylphosphoryl-choline together with sorbitol and its application to studying the metal and detergent requirement of the enzyme. Anal. Biochem. 75:281-289.
35. Irizarry R, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. 2003. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4:249-264.
36. Arai H, Igarashi Y, Kodama T. 1995. Expression of the nir and nor genes for denitrification of Pseudomonas aeruginosa requires a novel CRP/FNR related transcriptional regulator, DNR, in addition to ANR. FEBS Lett. 371:73-76.
37. Vallet-Gely I, Sharp JS, Dove SL. 2007. Local and global regulators linking anaerobiosis to cupA fimbrial gene expression in Pseudomonas aeruginosa. J. Bacteriol. 189:8667-8676.
38. Miller JH. 1992. A short course in bacterial genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
39. Zhang X, Bremer H. 1995. Control of the Escherichia coli rrnB P1 promoter strength by ppGpp. J. Biol. Chem. 270:11181-11189.
40. Castang S, McManus HR, Turner KH, Dove SL. 2008. H-NS family members function coordinately in an opportunistic pathogen. Proc. Natl. Acad. Sci. U. S. A. 105:18947-18952.
41. Vasil M, Graham L, Ostroff RM, Shortridge VD, Vasil AI. 1991. Phospholipase C: molecular biology and contribution to the pathogenesis of Pseudomonas aeruginosa, p 34-47. In Homma J, Tanimoto H, Holder I, Hiby N, Doring G (ed), Pseudomonas aeruginosa in human diseases, vol 44. Karger, Basel, Switzerland.
42. Wargo MJ, Gross MJ, Rajamani S, Allard JL, Lundblad LK, Allen GB, Vasil ML, Leclair LW, Hogan DA. 2011. Hemolytic phospholipase C inhibition protects lung function during Pseudomonas aeruginosa infection. Am. J. Respir. Crit. Care Med. 184:345-354.
43. Anderson GG, Moreau-Marquis S, Stanton BA, O'Toole GA. 2008. In vitro analysis of tobramycin-treated Pseudomonas aeruginosa biofilms on cystic fibrosis-derived airway epithelial cells. Infect. Immun. 76:1423-1433.
44. Vasil ML, Stonehouse MJ, Vasil AI, Wadsworth SJ, Goldfine H, Bolcome RE, Chan J. 2009. A complex extracellular sphingomyelinase of Pseudomonas aeruginosa inhibits angiogenesis by selective cytotoxicity to endothelial cells. PLoS Pathog. 5:e1000420. doi:10.1371/journal.ppat. 1000420.
45. Trunk K, Benkert B, Quack N, Munch R, Scheer M, Garbe J, Jansch L, Trost M, Wehland J, Buer J, Jahn M, Schobert M, Jahn D. 2010. Anaerobic adaptation in Pseudomonas aeruginosa: definition of the Anr and Dnr regulons. Environ. Microbiol. 12:1719-1733.
46. McManus H, Dove SL. 2011. The CgrA and CgrC proteins form a complex that positively regulates cupA fimbrial gene expression in Pseudomonas aeruginosa. J. Bacteriol. 193:6152-6161.
47. Kang Y, Nguyen David T, Son Mike S, Hoang TT. 2008. The Pseudomonas aeruginosa PsrA responds to long-chain fatty acid signals to regulate the fadBA5 beta-oxidation operon. Microbiology 154(Pt 6):1584-1598.
48. Rahme LG, Stevens EJ, Wolfort SF, Shao J, Tompkins RG, Ausubel FM. 1995. Common virulence factors for bacterial pathogenicity in plants and animals. Science 268:1899-1902.
49. Vallet-Gely I, Donovan KE, Fang R, Joung JK, Dove SL. 2005. Repression of phase-variable cup gene expression by H-NS-like proteins in Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. U. S. A. 102:11082-11087.
50. Meissner A, Wild V, Simm R, Rohde M, Erck C, Bredenbruch F, Morr M, Romling U, Haussler S. 2007. Pseudomonas aeruginosa cupA-encoded fimbriae expression is regulated by a GGDEF and EAL domain-dependent modulation of the intracellular level of cyclic diguanylate. Environ. Microbiol. 9:2475-2485.
51. Bates DM, Lazazzera BA, Kiley PJ. 1995. Characterization of Fnr mutant proteins indicates two distinct mechanisms for altering oxygen regulation of the Escherichia coli transcription factor Fnr. J. Bacteriol. 177: 3972-3978.
52. Worlitzsch D, Tarran R, Ulrich M, Schwab U, Cekici A, Meyer KC, Birrer P, Bellon G, Berger J, Weiss T, Botzenhart K, Yankaskas JR, Randell S, Boucher RC, Doring G. 2002. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J. Clin. Invest. 109:317-325.
53. Platt MD, Schurr MJ, Sauer K, Vazquez G, Kukavica-Ibrulj I, Potvin E, Levesque RC, Fedynak A, Brinkman FSL, Schurr J, Hwang SH, Lau GW, Limbach PA, Rowe JJ, Lieberman MA, Barraud N, Webb J, Kjelleberg S, Hunt DF, Hassett DJ. 2008. Proteomic, microarray, and signature-tagged mutagenesis analyses of anaerobic Pseudomonas aeruginosa at pH 6.5, likely representing chronic, late-stage cystic fibrosis airway conditions. J. Bacteriol. 190:2739-2758.
54. Ray MA, Johnston NA, Verhulst S, Trammell RA, Toth LA. 2010. Identification of markers for imminent death in mice used in longevity and aging research. J. Am. Assoc. Lab. Anim. Sci. 49:282-288.
55. Kawakami T, Kuroki M, Ishii M, Igarashi Y, Arai H. 2010. Differential expression of multiple terminal oxidases for aerobic respiration in Pseudomonas aeruginosa. Environ. Microbiol. 12:1399-1412.
56. Bielecki P, Komor U, Bielecka A, Musken M, Puchalka J, Pletz M, Ballmann M, Martins dos Santos VAP, Weiss S, Haussler S. 2013. Ex vivo transcriptional profiling reveals a common set of genes important for the adaptation of Pseudomonas aeruginosa to chronically infected host sites. Environ. Microbiol. 15:570-597.
57. Velasco-García R, Villalobos MA, Ramirez-Romero MA, Mujica-Jimenez C, Iturriaga G, Munoz-Clares RA. 2006. Betaine aldehyde dehydrogenase from Pseudomonas aeruginosa: cloning, over-expression in Escherichia coli, and regulation by choline and salt. Arch. Microbiol. 185: 14-22.
58. O'Toole GA, Kolter R. 1998. Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol. Microbiol. 30:295-304.
59. Yoon SS, Hennigan RF, Hilliard GM, Ochsner UA, Parvatiyar K, Kamani MC, Allen HL, DeKievit TR, Gardner PR, Schwab U, Rowe JJ, Iglewski BH, McDermott TR, Mason RP, Wozniak DJ, Hancock RE, Parsek Noah TL, Boucher RC, Hassett DJ. 2002. Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Dev. Cell 3:593-603.
60. Kolpen M, Hansen CR, Bjarnsholt T, Moser C, Christensen LD, van Gennip M, Ciofu O, Mandsberg L, Kharazmi A, Dǒring G, Givskov M, Hiby N, Jensen P. 2010. Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa in cystic fibrosis. Thorax 65:57-62.
61. Aldallal N, McNaughton EE, Manzel LJ, Richards AM, Zabner J, Ferkol TW, Look DC. 2002. Inflammatory response in airway epithelial cells isolated from patients with cystic fibrosis. Am. J. Respir. Crit. Care Med. 166:1248-1256.
62. Grasemann H. 1998. Nitric oxide metabolites in cystic fibrosis lung disease. Arch. Dis. Child. 78:49-53.
63. Linnane SJ. 1998. Total sputum nitrate plus nitrite is raised during acute pulmonary infection in cystic fibrosis. Am. J. Respir. Crit. Care Med. 158: 207-212.
64. Van Alst NE, Wellington M, Clark VL, Haidaris CG, Iglewski BH. 2009. Nitrite reductase NirS is required for type III secretion system expression and virulence in the human monocyte cell line THP-1 by Pseudomonas aeruginosa. Infect. Immun. 77:4446-4454.
65. Sonnleitner EGN, Sorger-Domenigg T, Heeb S, Richter AS, Backofen R, Williams P, Hüttenhofer A, Haas D, Bläsi U. 2011. The small RNA PhrS stimulates synthesis of the Pseudomonas aeruginosa quinolone signal. Mol. Microbiol. 80:868-885.
66. Pessi G, Haas D. 2000. Transcriptional control of the hydrogen cyanide biosynthetic genes hcnABC by the anaerobic regulator ANR and the quorum-sensing regulators LasR and RhlR in Pseudomonas aeruginosa. J. Bacteriol. 182:6940-6949.
67. Fitzsimmons L, Hampel KJ, Wargo MJ. 2012. Cellular choline and glycine betaine pools impact osmoprotection and phospholipase C production in Pseudomonas aeruginosa. J. Bacteriol. 194:4718-4726.
68. Chen C, Beattie GA. 2008. Pseudomonas syringae BetT is a low-affinity choline transporter that is responsible for superior osmoprotection by choline over glycine betaine. J. Bacteriol. 190:2717-2725.
69. Fleischhacker A, Kiley PJ. 2011. Iron-containing transcription factors and their roles as sensors. Curr. Opin. Chem. Biol. 15:335-341.
70. Krieger R, Rompf A, Schobert M, Jahn D. 2002. The Pseudomonas aeruginosa hemA promoter is regulated by Anr, Dnr, NarL and integration host factor. Mol. Genet. Genomics 267:409-417. Jackson et al. 3104 jb.asm.org Journal of Bacteriology